Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,717 public trials 2,164 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Active, not recruiting

Atrasentan in Patients With Proteinuric Glomerular Diseases

NCT04573920

Conditions
Alport Syndrome, Autoimmune Diseases, Collagen Diseases, +26 more
Locations
  • Kidney Disease Medical Group Glendale, California, United States
  • Academic Medical Research Institute Los Angeles, California, United States
  • North America Research Institute San Dimas, California, United States
  • Stanford U School Of Medicine Stanford, California, United States
View all 33 locations
View Trial Details
Active, not recruiting

The Arteriovenous Vascular (AV) ACCESS Trial

NCT04646226

Conditions
Chronic Disease, Disease Attributes, End-stage Kidney Disease, +12 more
Locations
  • University of Alabama at Birmingham School of Medicine Birmingham, Alabama, United States
  • UCLA Los Angeles, California, United States
  • Johns Hopkins School of Medicine Baltimore, Maryland, United States
  • Atrium Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States
View Trial Details
Active, not recruiting

A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD

NCT05281328

Conditions
Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, +13 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • Mount Sinai Hospital New York, United States
  • The New York Presbyterian Hospital New York, United States
  • Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Active, not recruiting

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

NCT04514484

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Differentiated Thyroid Gland Carcinoma, +141 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
View Trial Details
Active, not recruiting

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

NCT02568267

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +91 more
Locations
  • Dignity Health St Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Cancer Center Duarte, California, United States
  • City of Hope Duarte - Comprehensive Cancer Center, Investigational Drug Services Duarte, California, United States
View all 130 locations
View Trial Details
Active, not recruiting

Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

NCT06225596

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • University of Miami - Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Mount Sinai Medical Center of Florida, Inc. Miami Beach, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 102 locations
View Trial Details
Active, not recruiting

APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)

NCT03615235

Conditions
Chronic Disease, Disease Attributes, Female Urogenital Diseases, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Miami / Miami Transplant Institute Miami, Florida, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
View all 18 locations
View Trial Details
Active, not recruiting

A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial

NCT04216290

Conditions
Bladder Urothelial Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
View all 216 locations
View Trial Details

Related conditions